{"altmetric_id":12908756,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Mary-Ellen Taplin, MD, Dana-Farber Cancer Institute"],"first_seen_on":"2016-10-23T07:34:02+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1477131742,"links":["https:\/\/clinicaltrials.gov\/show\/NCT00776594"],"nct_id":"NCT00776594","pubdate":"2008-10-20T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Androgen Deprivation Therapy +\/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.25,"score_history":{"1y":0.25,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":7578098,"mean":6.5350293264878,"rank":6562038,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":7578098,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":235769,"mean":12.609041990431,"rank":192308,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":235769,"percentile":1},"this_journal":{"total_number_of_other_articles":19963,"mean":9.9772841398657,"rank":17228,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":19963,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":782,"mean":7.9043457106274,"rank":638,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":782,"percentile":1}}},"demographics":[],"counts":{"total":{"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["43136639944"],"posts_count":1}},"posts":{"facebook":[{"title":"Androgen Deprivation Therapy +\/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy - Full Text View - ClinicalTrials.gov","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10151030811904945&id=43136639944","license":"public","citation_ids":[12908756],"posted_on":"2016-10-22T10:22:22+00:00","summary":"Clinical trial NCT00776594 for Prostate Cancer has been completed!\n\nThis clinical trial is sponsored by Dana-Farber Cancer Institute\n\nThe Official Title for this clinical trial is: Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +\/-","author":{"name":"Cantria Prostate Cancer","url":"https:\/\/www.facebook.com\/43136639944","facebook_wall_name":"Cantria Prostate Cancer","image":"https:\/\/graph.facebook.com\/43136639944\/picture","id_on_source":"43136639944"}}]}}